wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q40041197-39AF9F84-95A5-4FB0-A538-210A26CA066C
Q40041197-39AF9F84-95A5-4FB0-A538-210A26CA066C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40041197-39AF9F84-95A5-4FB0-A538-210A26CA066C
Phase 1 safety, pharmacokinetic and pharmacodynamic study of the cyclin-dependent kinase inhibitor dinaciclib administered every three weeks in patients with advanced malignancies.
P2860
Q40041197-39AF9F84-95A5-4FB0-A538-210A26CA066C
BestRank
Statement
http://www.wikidata.org/entity/statement/Q40041197-39AF9F84-95A5-4FB0-A538-210A26CA066C
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
f7560fad4c77dd0dc6af4327520ae2b05b9a17c2
P2860
BET inhibitors induce apoptosis through a MYC independent mechanism and synergise with CDK inhibitors to kill osteosarcoma cells